Lucid Diagnostics (LUCD) Institutional Ownership $1.28 +0.02 (+1.59%) Closing price 09/2/2025 04:00 PM EasternExtended Trading$1.26 -0.02 (-1.56%) As of 09:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lucid Diagnostics (NASDAQ:LUCD)CurrentInstitutional OwnershipPercentage74.01%Number ofInstitutional Buyers(last 12 months)21TotalInstitutional Inflows(last 12 months)$6.42MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$895.85K Get LUCD Insider Trade Alerts Want to know when executives and insiders are buying or selling Lucid Diagnostics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data LUCD Institutional Buying and Selling by Quarter Lucid Diagnostics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Bank of America Corp DE28,746$33K0.0%-33.0%0.026% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.37,768$43K0.0%N/A0.035% 8/13/2025 Invesco Ltd.35,617$41K0.0%N/A0.033% 8/13/2025 New York State Common Retirement Fund84,100$97K0.0%N/A0.078% 8/13/2025 Quadrature Capital Ltd24,917$29K0.0%N/A0.023% 8/12/2025 JPMorgan Chase & Co.32,718$38K0.0%+71,026.1%0.030% 8/8/2025 Intech Investment Management LLC36,354$42K0.0%N/A0.034% 8/8/2025 Geode Capital Management LLC1,577,369$1.81M0.0%+420.3%1.458% 7/23/2025 Traphagen Investment Advisors LLC29,295$34K0.0%N/A0.027% 7/8/2025 Parallel Advisors LLC40,000$46K0.0%N/A0.037% Get the Latest News and Ratings for LUCD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lucid Diagnostics and its competitors with MarketBeat's FREE daily newsletter. 6/27/2025 Goldman Sachs Group Inc.86,302$129K0.0%+35.7%0.080% 5/16/2025 Goldman Sachs Group Inc.86,302$129K0.0%+35.7%0.082% 5/16/2025 Alyeska Investment Group L.P.1,887,843$2.81M0.0%N/A1.791% 5/15/2025 Cubist Systematic Strategies LLC26,048$39K0.0%N/A0.025% 5/15/2025 Ghisallo Capital Management LLC422,004$629K0.1%N/A0.400% 5/14/2025 Northwestern Mutual Wealth Management Co.24,559$37K0.0%N/A0.023% 5/14/2025 Berkshire Asset Management LLC PA20,000$30K0.0%N/A0.019% 5/5/2025 Sargent Investment Group LLC43,500$65K0.0%-92.0%0.041% 4/22/2025 XML Financial LLC178,795$266K0.0%N/A0.197% 2/18/2025 Sunbelt Securities Inc.83,999$67K0.0%N/A0.142% 2/17/2025 Luminus Management LLC1,016,720$832K1.0%-11.8%1.713% 2/17/2025 Citadel Advisors LLC119,887$98K0.0%N/A0.202% 2/14/2025 Nantahala Capital Management LLC94,541$77K0.0%-25.2%0.159% 2/14/2025 Lido Advisors LLC140,016$115K0.0%+40.0%0.236% 2/12/2025 Geode Capital Management LLC279,504$229K0.0%+30.9%0.471% 2/11/2025 LPL Financial LLC53,391$44K0.0%+29.1%0.090% 1/27/2025 Sargent Investment Group LLC541,500$442K0.1%N/A0.913% 8/20/2024 Nantahala Capital Management LLC126,362$104K0.0%-15.6%0.241% 5/20/2024 Virtu Financial LLC34,671$28K0.0%+66.4%0.067% 8/14/2023 Luminus Management LLC878,378$1.22M0.4%+2.7%2.024% 2/13/2023 Levin Capital Strategies L.P.36,799$50K0.0%N/A0.094% 11/15/2022 Cantor Fitzgerald L. P.264,653$405K0.0%-20.7%0.698% 11/14/2022 Luminus Management LLC846,662$1.30M0.5%-3.1%2.232% 11/14/2022 Verition Fund Management LLC36,166$55K0.0%-22.6%0.095% 11/10/2022 Nantahala Capital Management LLC286,432$438K0.0%-7.3%0.755% 8/15/2022 Nantahala Capital Management LLC308,978$698K0.0%-2.0%0.815% 8/15/2022 Luminus Management LLC873,804$1.98M0.6%+15.7%2.304% 7/22/2022 Geneos Wealth Management Inc.42,450$98K0.0%-32.0%0.112% 6/2/2022 Verition Fund Management LLC36,166$122K0.0%N/A0.095% 5/23/2022 Cantor Fitzgerald L. P.333,717$1.12M0.1%-20.0%0.880% Washington prepares for war (Ad)While the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much bigger here at home. Emergency powers are being invoked, trillions are being mobilized, and the scale rivals anything we’ve seen since WWII. According to Porter Stansberry and Jeff Brown, a new economic arms race is already underway — one that could reshape markets, redirect capital, and impact billions of lives. They’ve just released an urgent briefing that explains what’s really happening behind the scenes, and which companies are positioned to benefit most.Click here now to watch the urgent wartime exposé2/15/2022KCL Capital L.P.10,000$54K0.0%N/A0.027% 2/15/2022 Covalis Capital LLP134,532$722K0.3%N/A0.365% 2/2/2022 New York State Common Retirement Fund13,800$74K0.0%N/A0.037% 2/1/2022 Kornitzer Capital Management Inc. KS133,000$714K0.0%N/A0.361% (Data available from 1/1/2016 forward) LUCD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LUCD shares? During the previous two years, 25 institutional investors and hedge funds held shares of Lucid Diagnostics. The most heavily invested institutionals were Alyeska Investment Group L.P. ($2.81M), Geode Capital Management LLC ($1.81M), Luminus Management LLC ($832K), Ghisallo Capital Management LLC ($629K), XML Financial LLC ($266K), Goldman Sachs Group Inc. ($129K), and Lido Advisors LLC ($115K).Learn more on Lucid Diagnostics' institutional investors. What percentage of Lucid Diagnostics' stock is owned by institutional investors? 74.01% of Lucid Diagnostics' stock is owned by institutional investors. Learn more on LUCD's institutional investor holdings. Which institutional investors have been buying Lucid Diagnostics' stock? Of the 22 institutional investors that purchased Lucid Diagnostics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Alyeska Investment Group L.P. ($1.89M), Geode Capital Management LLC ($1.34M), Sargent Investment Group LLC ($541.50K), Ghisallo Capital Management LLC ($422.00K), XML Financial LLC ($178.80K), Citadel Advisors LLC ($119.89K), and New York State Common Retirement Fund ($84.10K). How much institutional buying is happening at Lucid Diagnostics? Institutional investors have bought a total of 5,063,005 shares in the last 24 months. This purchase volume represents approximately $6.42M in transactions. Which of Lucid Diagnostics' major shareholders have been selling company stock? The following institutional investors have sold Lucid Diagnostics stock in the last 24 months: Sargent Investment Group LLC ($498K), Luminus Management LLC ($136.20K), Nantahala Capital Management LLC ($31.82K), and Bank of America Corp DE ($14.15K). How much institutional selling is happening at Lucid Diagnostics? Institutional investors have sold a total of 680,167 shares in the last 24 months. This volume of shares sold represents approximately $895.85K in transactions. Related Companies SMLR Major Shareholders CBLL Major Shareholders DCTH Major Shareholders SNWV Major Shareholders BFLY Major Shareholders RXST Major Shareholders CLPT Major Shareholders SMTI Major Shareholders NPCE Major Shareholders TCMD Major Shareholders This page (NASDAQ:LUCD) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucid Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lucid Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.